PIK3CA and peritoneum cancer: Tumor shrinkage (− 11.9%, − 6.1%) was observed in two patients (one with cervical cancer; one with peritoneal cancer) who had PIK3CA mutation in the helical domain (E542K or E545K) and/or amplification (Fig. 3c).